CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer
Song‐Yang Wu, Si-Wei Zhang, Ding Ma, Yi Xiao, Yin Liu, Li Chen, Xiao-Qing Song, Xiao-Yan Ma, Ying Xu, Wen-Jun Chai, Xi Jin, Zhi-Ming Shao, Yi‐Zhou Jiang
Topics & Concepts
CCL19ImmunotherapyTumor microenvironmentBreast cancerMedicineDendritic cellImmune systemTriple-negative breast cancerCancer immunotherapyCD8Cancer researchImmunologyCancerOncologyInternal medicineChemokineChemokine receptorCancer Immunotherapy and BiomarkersImmunotherapy and Immune ResponsesSingle-cell and spatial transcriptomics